GO
Loading...

South and Southeast Asia

More

  • CORRECTED-JetBlue names Robin Hayes CEO Thursday, 18 Sep 2014 | 5:09 PM ET

    Sept 18- JetBlue Airways named Robin Hayes, its current President, as chief executive, effective Feb. 16, 2015. Shares were up 5 percent after the bell at $11.90. Hayes replaces Dave Barger, its CEO of seven years.

  • JetBlue names Robin Hayes CEO Thursday, 18 Sep 2014 | 4:49 PM ET

    Sept 18- JetBlue Airways named Robin Hayes, its current President, as chief executive, effective Feb. 16, 2015. Shares were up 5 percent after the bell at $11.90. Hayes replaces Dave Barger, its CEO of one year.

  • Sept 18- Home improvement retailer Home Depot Inc said 56 million card details were likely stolen in a data breach between April and September at its stores in the United States and Canada. Criminals used unique, custom-built malware to evade detection in the breach, the company said.

  • Oracle quarterly revenue misses on weak hardware sales Thursday, 18 Sep 2014 | 4:35 PM ET

    Sept 18- Oracle Corp reported quarterly revenue below analysts' estimates, hurt by a 7.6 percent fall in hardware systems revenue. Net income was $2.18 billion, or 48 cents per share, down from $2.19 billion, or 47 cents per share, a year earlier. On an adjusted basis, Oracle earned 62 cents per share, less than the 64 cents expected on average by analysts.

  • Linux distributor Red Hat's revenue rises 19 pct Thursday, 18 Sep 2014 | 4:17 PM ET

    Sept 18- Red Hat Inc, the world's largest commercial distributor of the Linux operating system, reported a 19 percent increase in quarterly revenue, helped by strong subscription growth. Net income rose to $46.8 million, or 25 cents per share, in the second quarter ended Aug. 31, from $40.8 million, or 21 cents per share, a year earlier.

  • The drug, developed by Vivus Inc, is marketed in the United States and Canada by Auxilium Pharmaceuticals Inc. Vivus' stock was up about 13 percent at $4.40 in afternoon trading.

  • The drug was developed by Auxilium Pharmaceuticals Inc and Vivus Inc.. Vivus owns the worldwide development and commercial rights to Stendra for use in sexual dysfunction, with the exception of certain Asian countries in the Pacific Rim.

  • *Visa exploring options for 5.5 pct stake in Monitise. *Visa fourth-biggest stakeholder in Monitise. Sept 18- Monitise Plc lost more than a third of its market value after Visa Inc, its biggest customer, revealed plans to divest its stake in the company and pursue development of its own mobile payment systems.

  • The drug, developed by Vivus Inc, is marketed in the United States and Canada by Auxilium Pharmaceuticals Inc. Vivus' stock was up about 13 percent at $4.40 in afternoon trading.

  • Alibaba IPO expected to be priced within range - CNBC Thursday, 18 Sep 2014 | 12:42 PM ET

    Sept 18- Chinese e-commerce giant Alibaba Group Holding Ltd's initial public offering is expected to be priced within the existing range of $66 to $68 per share, CNBC reported, citing sources familiar with the situation. Advisers have recommended a price of $68 per share, but Alibaba will choose the final price after a board meeting on Thursday, the report said.

  • FACTBOX-Underwriters in charge of Alibaba's mega IPO Thursday, 18 Sep 2014 | 12:01 PM ET

    Sept 18- Thirty-five underwriters are working to ensure that Alibaba Group Holding Ltd's initial public offering lives up to its blockbuster expectations when the stock starts trading on Friday. Morgan Stanley& Co International Plc. China International Capital Corp Hong Kong Securities Ltd.

  • Sept 18- Rite Aid Corp cut its full-year profit forecast for the second time in about three months due to lower margins in its pharmacy business, sending its shares down more than 16 percent.

  • UPDATE 1-Penn West says revamping accounting practices Thursday, 18 Sep 2014 | 9:40 AM ET

    Sept 18- Canadian oil producer Penn West Petroleum Ltd said it was strengthening its accounting practices after a review uncovered irregularities that forced to company to restate some of its prior results.

  • Sept 18- Rite Aid Corp, the third-largest U.S. drugstore chain, cut its full-year profit forecast for the second time, citing lower margins in its pharmacy business, sending its shares down 11 percent in premarket trading.

  • IHS, whose businesses include Cambridge Energy Research Associates and technology market research firm iSuppli, raised its revenue forecast to $2.23 billion- $2.24 billion for the full year ending Nov. 30, from its previous range of $2.17 billion- $2.23 billion.

  • Sept 18- Stock market indexes provider MSCI Inc declared its first-ever quarterly dividend and more than doubled its stock repurchase program to $850 million from $300 million. MSCI will pay Goldman Sachs $300 million in cash and expects to receive about 4.5 million shares of its common stock.

  • NEW DELHI, Sept 18- A standoff between Indian and Chinese soldiers overshadowed a visit to New Delhi by Chinese President Xi Jinping on Thursday, with a $20 billion investment pledge eclipsed by robust comments from India's new Prime Minister Narendra Modi about the dispute.

  • Penn West may have to review results since 2007 Thursday, 18 Sep 2014 | 8:23 AM ET

    Sept 18- Canadian oil producer Penn West Petroleum Ltd, under fire after it uncovered accounting irregularities in July, said its audit committee determined that the company needs to review results going back to 2007..

  • Sept 18- Stock market indexes provider MSCI Inc declared its first-ever quarterly dividend and more than doubled its stock repurchase program to $850 million from $300 million.

  • NEW DELHI, Sept 18- China became the latest nation to line up for a stake in India's civil nuclear energy drive on Thursday, agreeing to open talks on cooperation in a sector that New Delhi sees as the solution to its chronic power problems.